chrisvoncsefalvay/vaers-outcomes huggingface dataset:
short term memory loss for three days; headache; fatigue; Initial information received on 11-Jan-2022 regarding an unsolicited valid non-serious case was received from an other health professional.  This case involves an unknown age female patient who experienced short term memory loss for three days, headache and fatigue while receiving vaccine MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE [MENQUADFI].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a  dose of suspect MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE (lot U6821AA, expiry date: 27-Jun-2023, anatomical location: unknown) as prophylactic vaccination.  On an unknown date the patient developed a non-serious "short term memory loss for three days (amnesia)" (unknown latency) following the administration of MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE. On an unknown date the patient developed a non-serious "headache" (unknown latency) following the administration of MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE. On an unknown date the patient developed a non-serious "fatigue" (unknown latency) following the administration of MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE. Relevant laboratory test results included: Blood test - On an unknown date:  [normal]  It was reported "She states that the patient is reporting that she had short term memory loss for three days. She states that she also had the normal side effects like headache and fatigue right after the injection but she also doesn't remember the three days after the shot. She states that she "saw psych and is seeing neuro" and her blood work has been normal. She states that she is in between patients so she declined to provide additional AE information. No additional information from primary intake; caller refused to respond to questions and has accepted follow-up"  Action taken with MENINGOCOCCAL VACCINE (MENQUADFI) was not applicable.  It was not reported if the patient received a corrective treatment for the events (short term memory loss for three days, headache, fatigue).  At time of reporting, the outcome was Unknown for the event short term memory loss for three days, was Unknown for the event headache and was Unknown for the event fatigue.
Headache most frontal more pronounced overnight frontal sinus- 4-5 hours after second dose of vaccine Fever, myalgia and chill 12 hours post vaccination - took Tylenol and Motrin around the clock Intermittent wheezing. It's January 10 pm and I am still having above mentioned symptoms but intensity is significantly less.
patient experience pain and swelling after immunization. used some warm compression and the swelling went away but the pain still exist. also can't rotate her hand backward, this start about an hour after immunization. per patient, went to see doctor 3 times, got some pain reliever over the counter but it doesn't help to relieve the pain. Patient have an exam on the should at 12/15 still pending for the result. pt did not complain of any fever
Beginning the day I got the 2nd shot, I had arm pain./severe arm pain/hand in the arm I got the shot; chills; fever (100.7° F); nausea; muscle aches; loss of appetite; joint pain/elbow, wrist; severe arm pain that radiated to my armpit, back, elbow, wrist, and hand in the arm I got the shot; severe arm pain that radiated to my armpit, back, elbow, wrist, and hand in the arm I got the shot; This is a spontaneous report from a contactable other Health Professional (patient). A 22-year-old female patient received her second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via intramuscular on 07Jan2021 09:45 at single dose in left arm for covid-19 immunization. Medical history included OCD (obsessive-compulsive disorder)/anxiety, obesity. The patient had no allergies to medications, food, or other products. Concomitant medications the patient received within 2 weeks of vaccination included fluvoxamine and ethinylestradiol, norgestimate (SPRINTEC). The patient received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date for COVID-19 immunization. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 07Jan2021 22:45, beginning the day the patient got the 2nd shot, the patient had arm pain. That night (on 07Jan2021 22:45), she had chills, fever (100.7 F), nausea, muscle aches, loss of appetite, joint pain, and severe arm pain that radiated to her armpit, back, elbow, wrist, and hand in the arm she got the shot. This all lasted about 24 hours. The arm pan has been present for about 2 days now. No treatment was received. The outcome of the event arm pain was recovered on 09Jan2021; the outcome of the rest events was recovered on 08Jan2021.  information on the lot/batch number has been requested.
Dizziness, Blurry vision, pt fainted for one second. Evaluated by EMS-Cleared
Symptoms Nasal congestion Coughing  Fatigue My husband tested negative, so I didn?t test 06/06/2022 I developed a fever 101.4 and at this point me and my husband decided to test, and they were both positive. I used over the counter medication  06/08 Still have symptoms with no resolve so I contacted my doctor. Video visit with a doctor in my PCP office and they offered the antibodies/Paxlovid. I decided to take the Paxlovid.  I started taking the medication for the next five days and I saw a change within 24 hours. As of 07/18/2022 I feel like I am at about 95% although at times I get tired if I try to walk really fast up a steep hill I get shortness of breath.
This case was reported by a consumer (subject's father) and described the occurrence of threw up in a 4-month-old male subject who was vaccinated with ROTARIX (GlaxoSmithKline). A physician or other healthcare professional has not verified this report. Concurrent vaccination included two unspecified vaccines ;manufacturer unspecified ;unknown given on 11 November 2012. On 11 November 2011 at 16:00 the subject received unspecified dose of ROTARIX (oral). On 11 November 2012, at 17:00, 1 hour after vaccination with ROTARIX, the subject experienced threw up The subject's father consulted with a healthcare professional. At the time of reporting the outcome of the event was unspecified.
Constant joint pain in right arm; mild pain in right arm; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 17May2021 (at the age of 50-year-old), as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 17Apr2021, as a single dose for COVID-19 immunisation. On 23Jun2021, the patient experienced constant joint pain in right arm and mild pain in right arm. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event constant joint pain in right arm and mild pain in right arm was not resolved at the time of this report.
The most incredibly intense soreness and pain in every muscle for months and months as well as general inflammation.   Now, over a year later the intensity has subsided but still experience sore muscles everywhere for every activity and inflammation is still a problem
This spontaneous prospective pregnancy report was received from a physician via the company representative concerning a female patient of unknown age. The patient's concurrent conditions and medical history were not reported. On an unknown date the patient was inadvertently exposed to GARDASIL during pregnancy. Concomitant medications were not reported. No adverse effects were reported. The LMP and EDD were not known. The pregnancy outcome was pending. Additional information is not expected since the reporting physician did not wish to be contacted.
Left arm hurts more than when they got the second dose; Pain feels muscular and inflamed and has spread across the chest, mostly over the left breast area; The pain feels muscular and inflamed; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Left arm hurts more than when they got the second dose), PAIN (Pain feels muscular and inflamed and has spread across the chest, mostly over the left breast area), INFLAMMATION (The pain feels muscular and inflamed) and HEADACHE (Headache) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045C21A) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included HYDROXYCHLOROQUINE SULFATE (PLAQUENIL S), PREGABALIN, PREDNISONE, MYCOPHENOLATE MOFETIL HYDROCHLORIDE (CELLCEPT [MYCOPHENOLATE MOFETIL HYDROCHLORIDE]), CELECOXIB (CELEBREX), VITAMIN B12 NOS, BELIMUMAB, LANSOPRAZOLE, IRON and RIBOFLAVIN for an unknown indication.    On 17-Aug-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Aug-2021, the patient experienced HEADACHE (Headache). On an unknown date, the patient experienced PAIN IN EXTREMITY (Left arm hurts more than when they got the second dose), PAIN (Pain feels muscular and inflamed and has spread across the chest, mostly over the left breast area) and INFLAMMATION (The pain feels muscular and inflamed). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 18-Aug-2021, HEADACHE (Headache) had resolved. At the time of the report, PAIN IN EXTREMITY (Left arm hurts more than when they got the second dose), PAIN (Pain feels muscular and inflamed and has spread across the chest, mostly over the left breast area) and INFLAMMATION (The pain feels muscular and inflamed) outcome was unknown.            This case was linked to MOD-2021-290856 (Patient Link).
At night, I turned from one side to other. They whole room started spinning - lasted a couple of minutes. And then I turned to the other side and it happened again and then it happened a total of 4 times. I went back to sleep. I took Meclizine - to relieve symptoms. It made me sleepy for a couple of days. And then it happened again on Wednesday early AM. Since then I haven't had any more episodes. Later I had a physical therapy appt (per doctor advice after I told him about it) and she tried to move my head to try to trigger again and it didn't trigger the symptoms. She showed me exercises I can do if it happens again.
pt went to beach p/vax & that noc lt arm turned red from shoulder to elbow w/pain & swelling;lower grade temp;to MD office on 10OCT97 to report rxn;
This spontaneous report as received from a pharmacist refers to a newborn female patient of unknown age. On 07-NOV-2012 14:26, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. Two lot# were involved and the lot# were reported as: 0294AE, expiry date on 06-SEP-2014; and 0385AE, expiry date on 08-NOV-2014. It was unspecified which lot# the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
This spontaneous report was received from an office administrator and refers to an unspecified amount of patients (age and gender unknown). The reporter stated that on unknown dates in 2016, the patients received improperly stored doses of GARDASIL 9 (lot # L040054, expiration date: 26-DEC-2017). No adverse effects were reported. Temperature excursion occurred on 01-SEP-2016: Temperature: 45F Time frame: 18 hours. Digital data logger was involved. This is one of several reports received from the same source. Follow-up information was received on 28-DEC-2016: all telephone attempts to obtain follow-up information have been unsuccessful. Additional information has been requested. Sender's Comments: US-009507513-1612USA015140: US-009507513-1612USA015141: US-009507513-1612USA015142: MERCK 1610USA011550:Mfr number.
high fever; body ache; body chill; This is a spontaneous report from a contactable consumer (patient).   A 46 year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: not reported) (age at the vaccination 46-years-old), via an unspecified route of administration, administration on left arm on 17Mar2021 11.00 as dose 1, single for covid-19 immunization. Patient had no known allergies and no relevant medical history. The patient concomitant medications were not reported prior to two weeks. The patient was not pregnant at the time of vaccination. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experience high fever, body ache and body chill for 24 hours after 12 hours of administration that was on 17Mar2021 11.00. The patient had tylenol treatment for adverse event. The patient did not had covid prior to vaccination. The patient did not tested post vaccination. The outcome of events was recovered on an unspecified date in Mar2021.   No Follow-up attempts are possible. No information is expected further.
started sneezing; my sinuses were draining down; kind of felt like I had a sore throat; night sweats; slight fever off and on; night sweats; This spontaneous case was reported by a consumer and describes the occurrence of the first episode of NIGHT SWEATS (night sweats), SNEEZING (started sneezing), SINUSITIS (my sinuses were draining down), OROPHARYNGEAL PAIN (kind of felt like I had a sore throat) and the second episode of NIGHT SWEATS (night sweats) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 091D21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Shortness of breath on 15-Jul-2021, Weakness on 15-Jul-2021, Pain in extremity on 15-Jul-2021 and Nausea on 15-Jul-2021.    On 29-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jul-2021, the patient experienced the first episode of NIGHT SWEATS (night sweats) and PYREXIA (slight fever off and on). On 06-Aug-2021, the patient experienced the second episode of NIGHT SWEATS (night sweats). On 07-Aug-2021, the patient experienced SNEEZING (started sneezing), SINUSITIS (my sinuses were draining down) and OROPHARYNGEAL PAIN (kind of felt like I had a sore throat). At the time of the report, SNEEZING (started sneezing), SINUSITIS (my sinuses were draining down), OROPHARYNGEAL PAIN (kind of felt like I had a sore throat), the last episode of NIGHT SWEATS (night sweats) and PYREXIA (slight fever off and on) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Jul-2021, Body temperature (Unknown-97.5): 98 (High) fever of 98 degree F. On 06-Aug-2021, SARS-CoV-2 test: positive (Positive) tested positive for COVID-19.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.     Concomitant product use was not provided by the reporter.  Treatment medication was not provided by the reporter.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded
Fever, chills, stomach upset, cramping, diarrhea, fatigue, body aches
Patient developed symptoms of MISC on 1/28/22; fevers began on 1/29/22 with a Tmax of 49.4 degrees Celsius.  Over the course of illness, symptoms and complications included fevers, abdominal pain, mucocutaneous lesions/conjunctivitis, headache, aseptic meningitis and near syncope. Abnormal labs included elevated NT-ProBNP, elevated CRP, elevated D-dimer, and elevated CSF WBC count. Patient was admitted to the hospital on 2/2/22 and treated with IVIG, infliximab, and aspirin. She was discharged on 2/6/22.
mmunization record reviewed, HPV, menactra and Tdap immunizations recommended.   Screening reviewed - no contraindications/precautions.     Consent obtained and VIS provided - client's questions answered.  Immunizations administered under Standing Orders as in Orders.   Client observed for adverse reactions -  adverse reaction response:  Patient entered the exam room and went to sit on the exam table.  Writer showed patient's mother the vaccine and verified that the HPV, Menactra and Tdap were in the syrnges and ready for administration.  Patient was nervous and reluctant to take off jacket.  With encouragement from her mother and writer, patient removed her jacket.  Both arms were tense and she was holding on to the left side of the exam table.  With encouragment from writer and patient's mother patient let go of table and attempted to relax. She recieved the menactra vaccine to her left arm IM and giggled saying it didn't hurt that bad.  Writer administered the Tdap in the Left Deltoid at which time, patient said, 'oh that hurt." She then puffed out her cheeks which looked like she was holding her breath, she stiffened and then she became flaccid with eyes open and was laid on her back on the exam table by her mother and this writer.  She turned slightly to her right, facing her mother, tonic clonic movement was noted in both arms and legs as well as her head.  Patient's eyes were open. This lasted 40 seconds.  She was breathing and her mucus membrane color remained pink. after 20 seconds patient raised her head and said what happened.  She was distressed and started crying.  She said her face felt like it was buzzing.  Writer called for assistance and offered patient support and a popcycle which she ate slowly.  She took drank some water as well. She did not become naseaus nor was she incontent of urine or stool.  Mother declined to have the HPV vaccine given.  At 0945, Writer notified Dr. via telephone, Dr. wanted patient observed for 20 minutes and if there was a concern by writer or patient mother, Dr. recommended patient go to urgent care.   BP was 104/60 pulse 62 and  Respirations 18.  Patient repoted that she felt dizzy after the second shot and it was reported that patient had not eaten today.   Patient and mother were given verbal support and reasurrance by writer.  Patient's mother reported that patient's grandmother had a seizure diagnosis, took medications which controled the seizures.   Patient got down from table, walking around in the exam room, she denied visual changes or feeling dizzy, she denied light, sound or color changes before the episode.  She stated she felt okay.  Mother stated she wanted to take her daughter to the ED for evaluation.   Writer informed the mother and patient that due to this episode the PHO would not be able to give her anymore vaccines, but that she could recieve any additional vaccines at a providers office if approved by the provider.  Both mother and daughter left the clinic without further incident.
Red, warm, swollen tissue around the site of injection. Cellulitis. Keflex given 250mg three times per day.
Initial report received from a non healthcare professional social media on 16 December 2013. A patient of unknown age and gender had received TDAP (lot number: unknown) on unknown date. On 16 December 2013, the patient reported that vaccine made patient feel like crap. Laboratory investigations and corrective medications were not reported. At the time of this report the outcome was unknown. Documents held by sender: None. Follow-up information received on 23 December 2013. Additional MIS number: 13-0952 was added.
SUSPECTED COVID-19 INFECTION; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported. Per procedure no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient experienced suspected covid-19 infection. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of suspected covid-19 infection was not reported. This report was non-serious. This report was associated with a product quality complaint: 90000264965.
Anaphylactic reaction; Eyes swollen; This is a spontaneous report from a contactable Other Health Care Professional (reporting on her-self). A 55-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, lot number: EP6955 and Expiry date was not re-ported), via an unspecified route of administration on 06Apr2021 13:35 as single dose for COVID-19 immunization. Medical history included diabetes mellitus, fibromyalgia, intervertebral disc de-generation, post-traumatic stress disorder, back disorder all from an unknown date and unknown if ongoing. Concomitant medication(s) included metformin (METFORMIN) taken for diabetes mellitus, start and stop date were not reported; gabapentin (GABAPENTIN) taken for fibromyalgia, start and stop date were not reported; duloxetine hydrochloride (CYMBALTA) taken for fibromyalgia, post-traumatic stress disorder, start and stop date were not reported; naproxen (NAPROXEN) taken for back disorder, start and stop date were not reported. The patient previously 'Incurin' and 'Epitab' and experienced anaphylactic reaction. Historical vaccine includes first dose of bnt162b2 for covid-19 immunisation. It was reported that on 06Apr2021 at 13:35, patient had her second BNT162B2 vaccine. she ended up having an anaphylactic reaction was hospitalized and just got out today. She also want to say she have a history of having anaphylactic reaction from three different medication 'Incurin' and 'Epitab'. Patient stated that she had nothing wrong after the first one. Patient is a Nurse but not working right now. she was disabled (Further not clarified if consumer is physically disabled or financially) but she was a nurse. Patient was hospitalized on 06Apr2021. patient stated, she, was better. Her eyes are still swollen but she breathing when she went to hospital. Consumer stated for laboratory work Well in hospital they got lab, not before the vaccine and in the hospital they did lab when she got admitted in the hospital. Patient stated since she got in the hospital she have to take Prednisone for 5 days and Benadryl (treatment) for 5 days. she just got out of the hospital. The outcome of the event Anaphylactic reaction was recovering and for event eyes swollen was not recovered.; Sender's Comments: The events was considered related to suspect drug based on strong temporal association and known safety profile of the drug. however, the contribution of age and underlying medical conditions cannot be excluded.
Breakthrough COVID infection in fully vaccinated patient. Positive date 08/02/2021.